1. Home
  2. CPRX vs ENVA Comparison

CPRX vs ENVA Comparison

Compare CPRX & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • ENVA
  • Stock Information
  • Founded
  • CPRX 2002
  • ENVA 2011
  • Country
  • CPRX United States
  • ENVA United States
  • Employees
  • CPRX N/A
  • ENVA N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • ENVA Finance: Consumer Services
  • Sector
  • CPRX Health Care
  • ENVA Finance
  • Exchange
  • CPRX Nasdaq
  • ENVA Nasdaq
  • Market Cap
  • CPRX 2.9B
  • ENVA 2.4B
  • IPO Year
  • CPRX 2006
  • ENVA N/A
  • Fundamental
  • Price
  • CPRX $21.81
  • ENVA $114.87
  • Analyst Decision
  • CPRX Strong Buy
  • ENVA Buy
  • Analyst Count
  • CPRX 6
  • ENVA 7
  • Target Price
  • CPRX $32.83
  • ENVA $126.33
  • AVG Volume (30 Days)
  • CPRX 1.4M
  • ENVA 339.0K
  • Earning Date
  • CPRX 08-06-2025
  • ENVA 07-24-2025
  • Dividend Yield
  • CPRX N/A
  • ENVA N/A
  • EPS Growth
  • CPRX 178.13
  • ENVA 52.89
  • EPS
  • CPRX 1.57
  • ENVA 8.48
  • Revenue
  • CPRX $534,645,999.00
  • ENVA $1,304,376,000.00
  • Revenue This Year
  • CPRX $16.37
  • ENVA $158.51
  • Revenue Next Year
  • CPRX $8.80
  • ENVA $12.99
  • P/E Ratio
  • CPRX $13.93
  • ENVA $13.54
  • Revenue Growth
  • CPRX 29.97
  • ENVA 21.58
  • 52 Week Low
  • CPRX $15.34
  • ENVA $63.07
  • 52 Week High
  • CPRX $26.58
  • ENVA $119.06
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 42.36
  • ENVA 73.93
  • Support Level
  • CPRX $20.62
  • ENVA $114.51
  • Resistance Level
  • CPRX $22.06
  • ENVA $118.05
  • Average True Range (ATR)
  • CPRX 0.66
  • ENVA 3.07
  • MACD
  • CPRX 0.03
  • ENVA 0.74
  • Stochastic Oscillator
  • CPRX 56.67
  • ENVA 82.75

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

Share on Social Networks: